No. | Publication Date | Citing Article |
---|---|---|
1 | 2024 | Paula Alejandra Coccia, Laura Fernanda Alconcher, Veronica Ferraris, Lucas Ivan Lucarelli, Maria Agostina Grillo, Andrea Arias, Mariana Saurit, Viviana Marcela Ratto, Caludia Andrea Raddavero, Celia Dos Santos, Analía Sanchez Lucero. Eculizumab as first line treatment for patients with severe presentation of Complement Factor H antibodies mediated Hemolytic Uremic Syndrome. 1;. https://doi.org/10.21203/rs.3.rs-4492192/v1 |